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Abstract
Background: Prisons are known to be high-risk environments for the spread of bloodborne and
sexually transmitted infections. Prison officers are considered to have an intermittent exposure
potential to bloodborne infectious diseases on the job, however there has been no studies on the
prevalence of these infections in prison officers in Ghana.
Methods: A national multicenter cross-sectional study was undertaken on correlates of human
immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis
infections in sample of prison inmates and officers from eight of ten regional central prisons in
Ghana. A total of 1366 inmates and 445 officers were enrolled between May 2004 and December
2005. Subjects completed personal risk-factor questionnaire and provided blood specimens for
unlinked anonymous testing for presence of antibodies to HIV, HCV and Treponema pallidum; and
surface antigen of HBV (HBsAg). These data were analyzed using both univariate and multivariate
techniques.
Results: Almost 18% (1336) of 7652 eligible inmates and 21% (445) of 2139 eligible officers in eight
study prisons took part. Median ages of inmates and officers were 36.5 years (range 16–84) and
38.1 years (range 25–59), respectively. Among inmates, HIV seroprevalence was 5.9%, syphilis
seroprevalence was 16.5%, and 25.5% had HBsAg. Among officers tested, HIV seroprevalence was
4.9%, HCV seroprevalence was 18.7%, syphilis seroprevalence was 7.9%, and 11.7% had HBsAg.
Independent determinants for HIV, HBV and syphilis infections among inmates were age between
17–46, being unmarried, being illiterate, female gender, being incarcerated for longer than median
time served of 36 months, history of homosexuality, history of intravenous drug use, history of
sharing syringes and drug paraphernalia, history of participation in paid sexual activity, and history
of sexually transmitted diseases. Independent determinants for HIV, HBV, HCV and syphilis
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infections among officers were age between 25–46, fale gender, being unmarried, being employed
in prison service for longer than median duration of employment of 10 years, and history of sexually
transmitted diseases.
Conclusion: The comparably higher prevalence of HIV, HBV, HCV and syphilis in prison inmates
and officers in Ghana suggests probable occupational related transmission. The implementation of
infection control practices and risk reduction programs targeted at prison inmates and officers in
Ghana is urgently required to address this substantial exposure risk.
Background
Prison populations are considered to be at high risk for
bloodborne and sexually transmitted infections, such as
the human immunodeficiency virus (HIV), hepatitis B
virus (HBV), hepatitis C virus (HCV), and syphilis, due to
the high proportion of intravenous drug users (IDU),
commercial sex workers (CSW), men who have sex with
men (MSM), and the homeless [1,2]. There is growing evi-
dence that these infections have actually been transmitted
to individuals while they were in prison [3-8], although
there is also evidence that some had these infections
before they were incarcerated. Numerous studies have
estimated the occupational risk of exposure and infection
with bloodborne pathogens for hospital-based and cor-
rectional healthcare workers (category I workers with reg-
ular or frequent exposure potential) [9-14], but similar
data are sparse for prison officers not employed in health-
care delivery (PONEIHD, Category II workers with inter-
mittent exposure potential). This is a concern not only
because of high prevalence rates of bloodborne and sexu-
ally transmitted infectious diseases among prison
inmates, but also because numerous challenges to the
implementation of standard infection control practices in
the correctional setting have been identified [15-17].
Additionally, although risk reduction recommendations
to prevent the transmission of bloodborne pathogens in
hospitals have been promulgated and evaluated, the
degree of implementation and effectiveness of similar rec-
ommendations targeting correctional facilities remains
largely unknown [18].
Data on the prevalence and risk factors for HIV, HBV,
HCV and syphilis infections in prisoners are scanty in
Africa. We recently reported a higher prevalence of these
infections in inmates and correctional officers of 2
regional central prisons in Ghana compared to the general
Ghanaian population [19]. The seroprevalence of HIV,
HBV, HCV and syphilis in prisoners was 19.2%, 17.4%,
19.2% and 11%, respectively, and comparable to 8.5%,
3.7%, 23.2% and 4.9%, respectively among the prison
officers in these 2 sampled prisons in Ghana [19]. A simi-
lar seroepidemiology survey in prisoners and prison offic-
ers in Italy reported comparable HbsAg carrier rate of
6.7% in prisoners and 6.6% in prison officers [20]. A
more recent similar study in Greece reported a higher
HbsAg carrier rate of 20.0% in prison officers compared to
a rate of 13.3% in prisoners, but a lower HCV seropreva-
lence of 5.0% in prison officers compared to a seropreva-
lence of 15.5% in prisoners [21]. We recently
demonstrated that the higher seroprevalence of HCV in
Ghanaian prison inmates was probably due to prolonged
incarceration beyond 36 months, the higher proportion
of individuals with prior histories of intravenous drug use
and homosexual orientation/MSM (a high-risk sexual
behaviour) amongst Ghanaian prisoners, compared to
the general Ghanaian population [22].
To our knowledge, data on the risk factors associated with
the higher prevalence of HIV, HBV, HCV and syphilis
infections among prison inmates and officers in Ghana
are very scanty, and therefore discussion(s) about blood-
borne and sexually transmitted infections within the pris-
ons often requires extrapolation from data obtained in
other countries. Assessment of the extent and sources of
risk of these bloodborne infections for prison inmates and
officers in Ghana will facilitate decision making about
how to screen for these infections, prevent further spread
of these infections and provide appropriate care to
infected prison inmates and officers. The aim of this study
was to determine the prevalence and associated risk fac-
tors for HIV, HBV, HCV and syphilis infections among a
sample of prison inmates and officers stationed at eight of
the ten regional central prisons in Ghana.
Methods
Study sites
The study was designed as a national multicenter cross-
sectional study and was conducted between the months of
May 2004 and December 2005 among a convenient sam-
ple of male and female prison inmates and officers sta-
tioned at eight of the ten regional central prisons in
Ghana. Ghana is divided into ten administrative regions,
and the largest prison in each of these regions is the
regional central prison in each regional capital. All prison
or correctional officers in Ghana are not engaged or
employed in healthcare delivery (PONEIHD). All the
healthcare needs of the inmates and officers of the Ghana
Prison Service are provided by health care workers
(HCWs) employed by the Ghana Ministry of Health who
are stationed at the onsite prison clinic or the other terti-BMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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ary public hospital upon referral by the onsite prison
clinic. We enrolled inmates and officers from eight of
these ten prisons, but could not enrol from the other two
regional central prisons (Upper East Region and Upper
West Region Central Prisons) as originally planned
because of financial constraints. The study received ethical
approval from both the Ethical & Protocol Review Com-
mittee of the University of Ghana Medical School, Accra,
Ghana, and the Board of the Ghana Prison Service, Accra,
Ghana.
Study populations
The study was proposed to the entire population of prison
inmates and officers after an explanation of the purpose of
the study at a meeting organized for that purpose in each
of these prisons. They were informed that the study was
confidential and that the information provided would not
affect their incarceration and employment status, respec-
tively. A total of 1366 inmates and 445 officers consented
and were enrolled in the study. Written informed consent
was obtained from each participant, and the information
regarding the protocol and informed consent was pre-
sented to each participant at an appropriate literacy level.
No prison officer took part in the processes of obtaining
consent and collecting data in this study. This was to allay
fears of any possible victimization or security purpose of
the study by ensuring that no one was coerced into taking
part in any aspect of it. The study was conducted in a con-
fidential manner and unique study-generated identifiers,
not including the name of the participant, were used to
link questionnaires and serum samples; and this informa-
tion was only accessible to the principal investigator
(AAA). All participants were provided with pre- and post-
test counseling.
Personal risk-factor assessment questionnaire
The personal risk-factor assessment questionnaire was ini-
tially pilot tested on a small sample of prison inmates and
officers prior to the data collection. Sensitive personal risk
assessment questions were addressed in a composite risk
assessment question that incorporated less sensitive ques-
tions related to male-to-male sexual contact and illicit
intravenous drug use. However, this less sensitive com-
posite risk assessment question was left unanswered by all
the prison officers in the pilot testing, despite our assur-
ances of anonymity with study-generated identifiers
(rather than their names), confidentiality and non-disclo-
sure of results to their employer. Subsequent focus group
discussion with the prison officers participating in the
pilot testing revealed their discomfort with truthfully
answering this question and their lingering concerns
about possible employment victimization, despite our
assurances. Therefore, the final questionnaire for the offic-
ers did not include the composite question relating to
male-to-male sexual contact and illicit intravenous drug
use, since we were of the view that this question would be
left unanswered or not truthfully answered by the major-
ity of the prison officers.
Sample collection and serological analysis
Blood samples (about 6 ml) were collected in plain tubes
from each consenting participants. Samples were centri-
fuged and the serum kept at -20°C until analysed. Sera
were tested at the Virology Unit, Noguchi Memorial Insti-
tute for Medical Research, for the presence of antibodies
to HIV 1 and 2 (ELISA and Western Blot; Abbot and Cam-
bridge Biotech, respectively), antibodies to HCV (ELISA
and Western Blot; Abbot), antibodies to Treponema palli-
dum  [Treponema pallidum particle agglutination (TPPA)
test; Serodia Fujirebio] and HBsAg (monoclonal, ELISA;
Abbot), in accordance with the respective manufacturer's
instructions. Repeatedly reactive specimens by HIV and
HCV ELISA were assayed by Western blot.
Statistical analysis
The Statistical Analysis System (SAS Institute, Cary, NC,
USA) version 9.1 was used to complete all data analyses.
Odd ratios (ORs) and their 95% confidence interval (95%
CI) were used to compare proportions in independent
groups of categorical sociodemographic, sexual and
behavioural variables in univariate analysis. A P value of <
0.05 was considered significant. Multiple logistic regres-
sion models were developed to identify the independent
risk factors associated with positive test results and 95%
confidence intervals were calculated for adjusted ORs. The
categories of variables were combined into only two to
four categories to avoid large confidence intervals. The age
categories were based on thirds of the age distribution of
all the participating prison inmates and officers in the
study. Marital status was categorized as married or not
married (includes single, divorced or separated, and wid-
owed), and educational level attained by the inmates was
classified as illiterate or at least primary education. Time
served (from the beginning of their current period of
incarceration to the day of the survey) was categorized as
below the median of 36 months or above the median of
36 months, and sexual orientation was classified as heter-
osexual or homosexual (includes both MSM/gays and les-
bians). The duration of employment in the Ghana Prison
Service was categorized as below the median of 10 years or
above the median of 10 years. Finally, after incorporating
the data from our previous report on the correlates of
HCV infection in this same 1366 prisoners [22] with the
data of this study, univariate and multivariate analyses
were used to determine the associations between HIV,
HBV, HCV and syphilis infections among the 1366
inmates and 445 officers in Ghana.BMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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Results
Between May 2004 and December 2005, 1366 inmates
(17.9% of the total of 7652 eligible inmates in the eight
prisons studied) and 445 prison officers not engaged in
healthcare deliver (PONEIHD) [20.8% of the total of
2139 eligible prison officers stationed at the eight study
sites] in Ghana participated in the study. Of the 1366
study inmates, 1247 (91.3 %) were males and the median
age was 36.5 years (range 16–84). Of the 445 study offic-
ers, 278 (62.5%) were males and the median age was 38.1
years (range 25–59 years). The median duration of time
served (from the beginning of their current period of
incarceration to the day of the survey) was 36 months
(range 3–127 months). The median duration of employ-
ment in the Ghana Prison Service (from the beginning of
their employment to the day of the survey) was 10 years
(range 1.5–27 years). The above stated median age, per-
centage of participation at each of the eight study sites,
median duration of incarceration, and median duration
of employment were not statistically significantly differ-
ent between the male and female prison inmates and
officers (data not shown). The above stated sex (male:
female) ratio, median age, age range, median duration of
incarceration, and median duration of employment of the
study inmates and officers were similar to that of all the
eligible inmates and officers in these eight prisons at the
various periods of the study in each prison (Ghana Pris-
ons Service, 2005) (data not shown).
Table 1 shows the ORs and corresponding 95% CIs for
HIV and syphilis seropositivity, and positive HBsAg status
according to the sociodemographic characteristics of the
1366 study prisoners on univariate analysis. Table 2
shows the ORs and corresponding 95% CIs for HIV, HCV
and syphilis seropositivity, and positive HBsAg status
according to the sociodemographic characteristics of the
445 study prison officers on univariate analysis. Table 3
shows the ORs and corresponding 95% CIs for HIV and
syphilis seropositivity, and positive HBsAg status accord-
ing to the sociodemographic characteristics of the 1366
study prisoners on univariate analysis. Table 4 shows the
ORs and corresponding 95% CIs for HIV, HCV and syph-
ilis seropositivity, and positive HBsAg status according to
the sociodemographic characteristics of the 445 study
prison officers on univariate analysis. Table 5 shows the
ORs and corresponding 95% CIs for HIV and syphilis
seropositivity, and positive HBsAg status according to the
sexual and behavioural characteristics of the 1366 study
prisoners on univariate analysis. The results of multivari-
ate analysis confirmed that all the sociodemographic and
sexual behavoiural characteristics that reached statistical
significant in the univariate analysis presented in Tables 1,
2, 3, 4, 5 were independent determinants of the respective
infections (data not shown).
Among the 1366 study inmates, HIV seropositivity was
significantly associated with positive HBsAg status (OR
5.3; 95% CI 2.1–9.9), HCV seropositivity (OR 6.6; 95% CI
3.4–10.8) and syphilis seropositivity (OR 11.8; 95% CI
5.7–23.1). Positive HBsAg status was significantly associ-
ated with HIV seropositivity (OR 3.5; 95% CI 2.0–8.5),
HCV seropositivity (OR 3.6; 95% CI 2.1–8.8) and syphilis
seropositivity (OR 5.1; 95% CI 2.9–11.4). HCV seroposi-
tivity was significantly associated with HIV seropositivity
(OR 4.5; 95% CI 3.0–11.2), positive HBsAg status (OR
4.0; 95% CI 2.4–9.8) and syphilis (OR 4.1; 95% CI 2.6–
10.1) seropositivity. Finally, syphilis seropositivity was
significantly associated with HIV seropositivity (OR 5.9;
95% CI 3.2–14.1), positive HBsAg status (OR 6.1; 95% CI
Table 1: Odd ratios (ORs) and corresponding 95% confidence intervals (95% CIs) for HIV and syphilis seropositivity, and positive 
HBsAg status among the 1366 study inmates in eight regional central prisons in Ghana on univariate analysis
Regional central 
prison
No. of inmates HIV seropositive HBV seropositive Syphilis seropositive
Eligible Enrolled (%) No. (%) OR (95% CI)* No. (%) OR (95% CI)* No. (%) OR (95% CI)*
Ashanti region Kumasi 1370 145 (10.6) 5 (3.4) 7.8 (4.2–11.3) 28 (19.3) 1.5 (1.1–3.4) 40 (27.6) 5.7 (3.7–13.8)
Brong Ahafo region 
Sunyani
789 146 (18.5) 5 (3.4) 7.8 (4.2–11.3) 43 (29.5) 2.7 (2.0–7.6) 25 (17.1) 3.3 (2.4–9.5)
Central region Cape 
Coast
918 173 (18.8) 1 (0.6) 1.4 (0.9–2.6) 41 (23.7) 2.1 (1.8–5.3) 25 (14.5) 2.2 (1.9–5.6)
Eastern region Nsawam 1345 72 (5.4) 37 (51.4) 119.4 (87.2–131.7) 15 (20.8) 1.7 (1.3–3.9) 12 (16.7) 2.8 (2.2–8.1)
Greater Accra region 
James Fort & Camp
1497 209 (14.0) 17 (8.1) 18.5 (9.8–28.1) 34 (16.3) 1 19 (9.1) 1
Northern region Tamale 354 204 (57.6) 6 (2.9) 6.6 (3.4–9.9) 65 (31.9) 3.1 (2.3–8.9) 23 (11.3) 1.6 (1.2–3.7)
Volta region Ho 599 195 (32.6) 8 (4.1) 9.3 (5.5–13.7) 42 (21.5) 1.9 (1.5–4.5) 25 (12.8) 1.9 (1.4–4.2)
Western region Sekondi 780 222 (28.5) 1 (0.5) 1 81 (36.5) 3.7 (2.8–10.1) 57 (25.7) 4.5 (3.1–11.3)
Total 7652 1366 (17.9) 80 (5.9) 349 (25.5) 226 (16.5)
*Adjusted for age.BMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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3.6–15.7) and HCV seropositivity (OR 3.7; 95% CI 2.3–
9.4) [data not shown].
Among the 445 study officers not engaged in healthcare
delivery (PONEIHD), HIV seropositivity was significantly
associated with positive HBsAg status (OR 11.1; 95% CI
6.0–16.7), HCV seropositivity (OR 11.4; 95% CI 6.2–
17.5) and syphilis seropositivity (OR 24.0; 95% CI 11.4–
39.6). Positive HBsAg status was significantly associated
with HIV seropositivity (OR 6.9; 95% CI 4.2–11.6), HCV
seropositivity (OR 3.5; 95% CI 2.2–7.6) and syphilis sero-
positivity (OR 6.2; 95% CI 3.5–10.9). HCV seropositivity
was significantly associated with HIV seropositivity (OR
5.3; 95% CI 2.8–9.9), positive HBsAg status (OR 3.2; 95%
CI 2.1–7.2) and syphilis seropositivity (OR 3.8; 95% CI
2.3–8.2). Finally, syphilis seropositivity was significantly
associated with HIV seropositivity (OR 14.6; 95% CI 8.3–
26.4), positive HBsAg status (OR 7.4; 95% CI 3.9–13.0)
and HCV seropositivity (OR 4.7; 95% CI 2.6–9.1) [data
not shown].
Discussion
Correctional facilities or prisons form part of the criminal
justice system and it is estimated that over 9 million peo-
ple are in penal institutions worldwide. Overcrowding in
prisons remains a concern in both developed and devel-
oping countries, and is a key causative factor for a myriad
of other problems which ultimately turn these custodial
settings into fertile breeding grounds for infectious dis-
eases such as AIDS, hepatitis, syphilis, gonorrhoea and
tuberculosis. Compared to the general population, pris-
oners worldwide continue to demonstrate a significantly
higher prevalence of bloodborne and sexually transmitted
infections [1-8,19,23-31]. Prison officers not engaged in
healthcare delivery (PONEIHD) [category II workers] are
recognized to be at increased risk for these infections
because of the high prevalence of these infections among
inmates and their close interaction with the inmates in the
performance of their job [32-34]. Knowledge of the corre-
lates of bloodborne viral infections and sexually transmit-
ted diseases (STDs) in different parts of the world, and
Table 2: Odd ratios (ORs) and corresponding 95% confidence intervals (95% CIs) for HIV, HCV and syphilis seropositivity, and positive 
HBsAg status among 445 prison officers stationed at eight regional central prisons in Ghana on univariate analysis
Regional central Prisons & Headquarters No. of inmates HIV seropositive HBV seropositive HCV seropositive Syphilis seropositive
Eligible Enrolled (%) No. (%) *OR (95% CI) No. (%) *OR (95% CI) No. (%) *OR (95% CI) No. (%) *OR (95% CI)
Ashanti region Kumasi 344 59 (17.2) 5 (8.5) 4.9 (3.0–9.8) 9 (15.3) 9.7 (5.5–15.2) 7 (11.9) 1.5 (0.9–3.3) 8 (13.6) 7.4 (3.8–13.4)
Brong Ahafo region Sunyani 159 66 (41.5) 5 (7.6) 4.4 (2.9–8.9) 9 (13.6) 8.6 (5.1–14.5) 13 (19.7) 2.4 (1.8–5.9) 8 (12.1) 6.6(3.6–12.1)
Central region Cape Coast 428 33 (7.7) 2 (6.1) 3.5 (2.5–7.7) 6 (18.2) 11.5 (6.2–17.6) 14 (42.4) 5.2 (3.2–11.5) 1 (3.0) 1.6 (1.1–3.8)
Eastern region Nsawam 338 49 (14.5) 2 (4.1) 2.4 (1.3–5.5) 1 (2.0) 1.3 (0.8–2.7) 5 (10.2) 1 2 (4.1) 2.2 (1.7–5.7)
Greater Accra region James Fort & Camp 154 54 (35.1) 1 (1.9) 1 1 (1.9) 1 6 (11.1) 1.4 (0.8–2.9) 8 (14.8) 8.1 (4.3–14.9)
Northern region Tamale 128 67 (52.3) 3 (4.5) 2.6 (1.5–6.0) 10 (14.9) 9.4 () 12 (17.9) 2.2 (1.6–5.4) 2 (3.0) 1.6 (1.1–3.8)
Volta region Ho 243 48 (19.8) 1 (2.1) 1.2 (0.7–2.3) 10 (20.8) 13.1 (7.3–22.4) 10 (20.8) 2.5 (1.9–6.2) 1 (2.1) 1
Western region Sekondi 345 69 (20.0) 3 (4.3) 2.5 (1.4–5.7) 6 (8.7) 5.5 (3.0–10.9) 16 (23.2) 2.8 (2.1–7.7) 5 (7.2) 3.9 (2.8–10.5)
Total 2139 445 (20.8) 22 (4.9) 52 (11.7) 83 (18.7) 35 (7.9)
*Adjusted for age.
Table 3: Odd ratios (ORs) and corresponding 95% confidence intervals (95% CIs) for HIV and syphilis seropositivity, and positive 
HBsAg status according to the sociodemographic characteristics among 1366 prisoners in Ghana on univariate analysis
Sociodemographic characteristic* No. of inmates (%) HIV seropositive HBV seropositive Syphilis seropositive
No. (%) OR (95% CI)# No. (%) OR (95% CI)# No. (%) OR (95% CI)#
Age (years)
17–31 455 (33.3) 37 (8.1) 3.9 (2.6–9.8) 178 (39.1) 3.2 (2.4–8.5) 111 (24.4) 3.3 (2.5–8.9)
32–46 458 (33.5) 30 (6.6) 3.1 (2.2–7.7) 105 (22.9) 2.4 (1.7–6.3) 71 (15.5) 2.2 (1.4–6.1)
>47 453 (33.2) 13 (2.9) 1 66 (14.5) 1 44 (9.7) 1
Marital status
Married 1030 (75.4) 34 (3.3) 1 197 (19.1) 1 102 (9.9) 1
Not married 336 (24.6) 46 (13.7) 5.9 (3.3–14.2) 152 (45.2) 2.9 (2.2–7.1) 124 (36.9) 4.9 (4.1–12.7)
Educational level attained
Primary or better 1123 (82.2) 48 (4.3) 1 219 (19.5) 1 117 (10.4) 1
Illiterate or none 243 (17.8) 32 (13.2) 4.2 (2.8–11.0) 130 (53.5) 3.7 (2.7–10.6) 109 (44.9) 5.6 (3.1–13.6)
Gender
Female 119 (8.7) 18 (15.1) 4.5 (3.0–13.4) 51 (42.9) 3.5 (2.5–9.8) 43 (36.1) 3.4 (2.3–8.5)
Male 1247 (91.3) 62 (5.0) 1 298 (23.9) 1 183 (14.7) 1
*Combined into only two to three categories to minimize the width of confidence intervals.
#Adjusted for age.B
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Table 4: Odd ratios (ORs) and corresponding 95% confidence intervals (95% CIs) for HIV, HCV and syphilis seropositivity, and positive HBsAg status according to the 
sociodemographic characteristics among 445 prison officers in Ghana on univariate analysis
Sociodemographic characteristic* No. of inmates (%) HIV seropositive HBV seropositive HCV seropositive Syphilis seropositive
No. (%) OR (95% CI)# No. (%) OR (95% CI)# No. (%) OR 95% CI)# No. (%) OR (95% CI)#
Age (years)
25–35 149 (33.4) 8 (5.4) 2.2 (1.5–5.4) 22 (14.8) 2.4 (1.8–6.4) 29 (19.5) 2.3 (1.7–5.9) 14 (9.4) 2.0 (1.5–4.9)
36–46 148 (33.3) 10 (6.8) 2.8 (2.0–7.8) 19 (12.8) 2.1 (1.5–5.2) 38 (25.7) 3.0 (2.2–8.9) 13 (8.8) 1.9 (1.4–4.7)
>47 148 (33.3) 4 (2.7) 1 11 (7.4) 1 16 (10.8) 1 8 (5.4) 1
Gender
Female 167 (37.5) 12 (7.2) 2.2 (1.5–5.4) 29 (17.4) 2.5 (1.8–6.7) 38 (22.8) 1.8 (1.3–4.5) 20 (12.0) 2.6 (1.9–7.0)
Male 278 (62.5) 10 (3.6) 1 23 (8.3) 1 45 (16.2) 1 15 (5.4) 1
Marital status
Married 203 (45.6) 8 (3.9) 1 20 (9.9) 1 33 (16.3) 1 12 (5.9) 1
Not married 242 (54.4) 14 (5.8) 1.6 (1.1–3.4) 32 (13.2) 1.6 (1.2–3.5) 50 (20.7) 1.6 (1.2–3.6) 23 (9.5) 1.9 (1.4–4.7)
Educational level attained
Middle School 144 (32.4) 9 (6.3) 1.5 (0.9–2.8) 20 (13.9) 1.4 (0.7–2.3) 30 (20.8) 1.3 (0.7–2.0) 14 (9.7) 1.5 (0.8–2.7)
Junior Secondary School 69 (15.5) 4 (5.8) 1.4 (0.9–2.6) 10 (14.5) 1.5 (0.9–2.8) 15 (21.7) 1.4 (0.8–2.3) 5 (7.2) 1.1 (0.5–1.8)
Senior Secondary School 212 (47.6) 8 (3.8) 1 21 (9.9) 1 34 (16.0) 1 14 (6.6) 1
University/College 20 (4.5) 1 (5.0) 1.3 (0.7–2.0) 2 (10.0) 1.0 (0.3–1.3) 4 (20.0) 1.3 (0.7–2.0) 2 (10.0) 1.5 (0.8–2.7)
Duration of employment in prison service (years)
Below median (<10) 223 (50.1) 9 (4.0) 1 20 (9.0) 1 33 (14.8) 1 15 (6.7) 1
Above median (>10) 222 (49.9) 13 (5.9) 1.6 (1.1–3.4) 32 (14.4) 1.9 (1.4–4.5) 50 (22.5) 1.9 (1.4–4.6) 20 (9.0) 1.5 (1.1–3.2)
History of STD
Yes 75 (16.9) 6 (8.0) 2.0 (1.4–4.7) 17 (22.7) 2.9 (2.1–8.2) 21 (28.0) 2.1 (1.5–5.3) 14 (18.7) 3.8 (2.6–10.5)
No 370 (83.1) 16 (4.3) 1 35 (9.5) 1 62 (16.8) 1 21 (5.7) 1
History of blood transfusion
Yes 90 (20.2) 5 (5.6) 1.3 (0.7–2.0) 11 (12.2) 1.3 (0.6–2.0) 19 (21.1) 1.5 (0.9–2.8) 8 (8.9) 1.3 (0.6–2.0)
No 355 (79.8) 17 (4.8) 1 41 (11.6) 1 64 (18.0) 1 27 (7.6) 1
Ever been tattooed or pierced
Yes 58 (13.0) 3 (5.2) 1.2 (0.6–1.9) 7 (12.1) 1.3 (0.6–2.0) 11 (19.0) 1.3 (0.7–2.0) 5 (8.6) 1.3 (0.6–2.0)
No 387 (87.0) 19 (4.9) 1 45 (11.6) 1 72 (18.6) 1 30 (7.8) 1
Ever been cut or assaulted
Yes 93 (20.9) 5 (5.4) 1.2 (0.6–1.9) 11 (11.8) 1.2 (0.5–1.8) 18 (19.4) 1.3 (0.7–2.0) 8 (8.6) 1.3 (0.6–2.0)
No 352 (79.1) 17 (4.8) 1 41 (11.6) 1 65 (18.5) 1 27 (7.7) 1
*Combined into only two to four categories to minimize the width of confidence intervals.
#Adjusted for age.BMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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particularly in Africa in the face of limited resources, is
important for the planning of preventive measures and
the development of vaccination programmes. Further-
more, the comparison of the prevalence among prison
inmates, prison officers and the general population in the
same geographical area is important to provide a basis for
action, and changes in public health policy, education
and clinical practice. Numerous studies have estimated
the occupational risk of exposure and infection with
bloodborne pathogens for hospital-based and correc-
tional healthcare workers (category I workers) [9-14], but
similar data are sparse for PONEIHD. Systematic surveil-
lance of HIV, HBV, HCV and syphilis in prison inmates
and officers in Ghana is completely absent, and there is no
formal program for institutionalized implementation of
standard infection control practices, bloodborne infec-
tious disease risk reduction recommendations, manda-
tory screening and HBV immunization upon employment
and treatment for both prison inmates and officers in the
Ghana Prison Service.
This study found higher overall seroprevalence rates of
HIV (5.9%), HBV (25.5%) and syphilis (16.5%) in Gha-
naian prisoners, as compared to the seroprevalence of
Table 5: Odd ratios (ORs) and corresponding 95% confidence intervals (95% CIs) for HIV and syphilis seropositivity, and positive 
HBsAg status according to the sexual behavioural characteristics among 1366 prisoners in Ghana on univariate analysis
Sexual and behavioural 
characteristic*
No. of inmates (%) HIV seropositive HBV seropositive Syphilis seropositive
No. (%) OR (95% CI)# No. (%) OR (95% CI)# No. (%) OR (95% CI)#
Time served (months)
Below median (<36) 682 (49.9) 15 (2.2) 1 59 (8.7) 1 36 (5.3) 1
Above median (>36) 684 (50.1) 65 (9.5) 6.3 (2.7–16.5) 290 (42.4) 7.1 (3.0–18.3) 190 (27.8) 7.6 (3.2–20.1)
Sexual orientation
Heterosexual 963 (70.5) 44 (4.6) 1 187 (19.4) 1 132 (13.7) 1
Homosexual 403 (29.5) 36 (8.9) 2.7 (1.9–7.8) 162 (40.2) 2.9 (2.2–8.3) 94 (23.3) 2.4 (1.5–6.9)
Ever injected drugs
Yes 481 (35.2) 55 (11.4) 5.7 (2.4–12.8) 237 (49.3) 5.4 (2.2–11.1) 152 (31.6) 5.3 (2.2–10.7)
No 885 (64.8) 25 (2.8) 1 112 (12.7) 1 74 (8.4) 1
Ever shared needles or 
injection implements
Yes 977 (71.5) 62 (6.3) 2.0 (1.3–5.2) 269 (27.5) 1.9 (1.2–5.0) 174 (17.8) 1.9 (1.2–5.1)
No 389 (28.5) 18 (4.6) 1 80 (20.6) 1 52 (13.4) 1
Ever paid or been paid for 
sex
Yes 73 (5.3) 8 (11.0) 2.8 (1.8–8.2) 27 (37.0) 2.1 (1.4–5.5) 19 (26.0) 2.3 (1.5–6.3)
No 1293 (94.7) 72 (5.6) 1 322 (24.9) 1 207 (16.0) 1
History of STD
Yes 491 (35.9) 46 (9.4) 3.4 (2.0–9.3) 178 (36.3) 2.6 (1.8–7.4) 113 (23.0) 2.5 (1.6–7.1)
No 875 (64.1) 34 (3.9) 1 171 (19.5) 1 113 (12.9) 1
History of blood transfusion
Yes 961 (70.4) 57 (5.9) 1.4 (0.8–2.7) 249 (25.9) 1.5 (0.9–2.9) 162 (16.9) 1.5 (0.8–2.8)
No 405 (29.6) 23 (5.7) 1 100 (24.7) 1 64 (15.8) 1
Ever had sex with an 
injection drug user
Yes 136 (10.0) 9 (6.6) 1.6 (0.9–3.1) 35 (25.7) 1.3 (0.6–2.3) 24 (17.6) 1.4 (0.8–2.6)
No 1230 (90.0) 71 (5.8) 1 314 (25.5) 1 202 (16.4) 1
Ever snorted drugs
Yes 598 (43.8) 37 (6.2) 1.4 (0.8–2.7) 155 (25.9) 1.3 (0.7–2.4) 101 (16.9) 1.3 (0.7–2.5)
No 768 (56.2) 43 (5.6) 1 194 (25.3) 1 125 (16.3) 1
Ever been tattooed or 
pierced
Yes 219 (16.0) 13 (5.9) 1.2 (0.5–1.8) 56 (25.6) 1.1 (0.4–1.5) 37 (16.9) 1.2 (0.6–1.8)
No 1147 (84.0) 67 (5.8) 1 293 (25.5) 1 189 (16.5) 1
Ever been cut or assaulted
Yes 423 (31.0) 25 (5.9) 1.2 (0.5–1.9) 109 (25.8) 1.2 (0.5–2.0) 71 (16.8) 1.1 (0.4–1.6)
No 943 (69.0) 55 (5.8) 1 240 (25.5) 1 155 (16.4) 1
*Combined into only two to three categories to minimize the width of confidence intervals.
#Adjusted for age.BMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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these infections previously reported in the general public
in Ghana, mainly healthy blood donors and pregnant
women [35-44]. The present study supports previous
reports that prisoners represent a high-risk group for
bloodborne diseases and STDs [1-8,19,23-31]. The overall
seroprevalence of HIV, HBV and HCV [22] among Ghana-
ian prisoners (5.9%, 25.5% and 18.7%, respectively) is
higher than the results of a similar study in incarcerated
populations in the United Kingdom (0.4%, 8.0% and
7.0%, respectively) [25]. Additionally, the overall sero-
prevalence of HIV, HBV, syphilis and HCV [22] among
Ghanaian prisoners (5.9%, 25.5%, 16.5% and 18.7%,
respectively) is higher than the results of a similar study in
incarcerated populations in Brazil (3.2%, 17.5%, 7.4%
and 6.3%, respectively) [28]. Finally, the overall seroprev-
alence of HBV and syphilis among Ghanaian prisoners
(25.5% and 16.5%, respectively) is higher than the results
of a similar study in incarcerated populations in the
United States of America (25.2% and 0.6%, respectively)
[45], however that of HIV and HCV [22] in Ghanaian pris-
oners (5.9% and 18.7%, respectively) is lower than that in
prisoners in the United States of America (6.6% and
29.7%, respectively) [45]. From the comparison above,
the higher prevalence among Ghanaian prisoners com-
pared to prisoners in the United States of America [45],
the United Kingdom [25] and Brazil [28] most probably
reflects the current absence of any harm reduction inter-
ventions in Ghanaian prisons whilst variable extent of
implementation of such interventions are currently in
place in prisons in the United States of America, the
United Kingdom and Brazil. However, the higher preva-
lence of HIV and HCV in prisoners in the United States of
America compared to Ghanaian prisoners (in whom no
harm reduction interventions have yet been imple-
mented) most probably reflects a persistently higher prev-
alence of intravenous drug use within and without the
prisons in the United States of America compared to
Ghana, despite the implementation of harm reduction
interventions within most prisons in the United States of
America.
This study found higher overall seroprevalence rates of
HIV (4.9%), HBV (11.7%), HCV (18.7%) and syphilis
(7.9%) in Ghanaian PONEIHD, as compared to the sero-
prevalence of these infections previously reported in the
general public in Ghana, mainly healthy blood donors
and pregnant women [35-44]. However, the seropreva-
lence in the prison officers is comparable but generally
lower to the similarly high seroprevalence observed in
prisoners in this study and previously reported in prison-
ers in Ghana (5.9%, 25.5%, 16.5% and 18.7%, respec-
tively) [19], though the seroprevalence of HCV was even
higher in the prison officers than the prisoners. Our
observed overall HBsAg carrier rate of 11.7% among Gha-
naian PONEIHD is higher than the results of a similar
seroepidemiology study in PONEIHD in Italy (6.6%),
which reported a comparable HBsAg carrier rate of 6.7%
in prisoners in Italy [20]. However, our observed overall
HBsAg carrier rate of 11.7% among Ghanaian PONEIHD
is lower than that of a similar study in PONEIHD in
Greece (20.0%), which was higher than the HBsAg carrier
rate of 13.3% in prisoners in Greece [21]. Our observed
HCV seroprevalence of 18.7% in Ghanaian PONEIHD is
much higher than that reported in PONEIHD in Greece
(5.0%), which was lower than the HCV seroprevalence of
15.5% in prisoners in Greece [21]. A more recent study
among correctional healthcare workers or prison officers
employed in healthcare delivery in three states in the
United States of America reported no evidence of chronic
HBV infection (ie, 0% HBsAg carrier rate) and 2% HCV
seroprevalence [10], which was much lower that that
herein reported for PONEIHD in Ghana and that previ-
ously reported for prison officers in Italy [20] and Greece
[21]. From the comparison above, the higher seropreva-
lence of especially HCV among Ghanaian prison officers
compared to prison officers in the United States of Amer-
ica [10], Italy [20] and Greece [21] most probably reflects
the current absence of any institutionalized infection con-
trol measures and harm reduction interventions in Gha-
naian prisons whilst variable extent of implementation of
such interventions are currently in place in prisons in the
United States of America, Italy and Greece.
The seroprevalence rates of HIV, HBV and syphilis infec-
tions were significantly higher in inmates aged 17–46
(which spans the generally accepted sexually-active age
group of 15–45 years), unmarried inmates, illiterate
inmates, female inmates, inmates incarcerated for longer
than the median time served of 36 months, inmates
reporting previous histories of homosexuality, of IDU, of
sharing drug paraphernalia, or participating in paid sex,
and of STD. These observed risk factors for all three infec-
tions in Ghanaian prisoners are generally considered as
indicators of either intravenous drug use (history of IDU
and sharing drug paraphernalia, and prolonged incarcera-
tion), high-risk sexual behaviour (sexually-active age
group, unmarried, homosexual orientation, participation
in paid sex and history of STD), or lower socioeconomic
status (illiterate and female gender). The seroprevalence
rates of HIV, HBV, HCV and syphilis infections were sig-
nificantly higher in prison officers aged 25–46 (which
spans the generally accepted sexually-active age group of
15–45 years), unmarried prison officers, female prison
officers, prison officers employed for longer than the
median duration of 10 years, and reporting a previous his-
tory of STD. These observed risk factors for all four infec-
tions in Ghanaian prison officers are related to the
duration of exposure to work in the prison environment,
high-risk sexual behaviour (sexually-active age group,
unmarried, and history of STD), or lower socioeconomicBMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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status (female gender). Our observed significant associa-
tions between HIV, HBV, HCV and syphilis seropositivity
status among the prison inmates and officers in Ghana
suggests that the transmission of all four infections may
be linked and are related to the same identified risk factors
above.
The herein reported seroprevalence rates of HIV, HBV,
HCV and syphilis are more representative of the Ghanaian
prison population, because of the much larger sample
size, than that previously reported [19]. The explanations
for the varied seroprevalence of the four infections
between the eight sites studied, and the variation in level
of participation between the eight study sites are not obvi-
ous from this study. The significantly higher prevalence of
these bloodborne and sexually transmitted infections in
female prison inmates and officers compared to their
male counterparts in Ghana is not unexpected, since sim-
ilar gender disparity has been reported in prisoners and
minority women in the southern United States of America
[46-50] driven by similar predisposing sexual and socioe-
conomic risk factors as we have described above in pris-
ons in Ghana. Addtionally, women are also more likely to
engage in commercial sex work (CSW), a high-risk sexual
behaviour that correlate with the prevalence of syphilis
and other STDs [29,51-53]. Our observed gender disparity
in the risk of these infections in the Ghanaian prison sys-
tem most probably also reflects the general lower socioe-
conomic status of women worldwide (but especially in
developing countries like Ghana), and emphasizes the
specific needs of women in the implementation of efforts
at reducing the risk for bloodborne and sexually transmit-
ted infections.
The results of this study suggest that PONEIHD in Ghana
may have exposure rates to bloodborne infections that are
comparable to those in published reports regarding hos-
pital-based health care workers (HCWs) [category I expo-
sure risk rather than category II exposure risk) [9,11,14].
This suggested level of exposure is surprising, since
PONEIHD in Ghana do not administer any acute health-
care to prisoners compared to that done by HCWs in acute
care hospitals. Apart from occupational exposure, the
exchange of sexual favours between prison officers and
inmates, which is not unheard of, may be another mitigat-
ing factor in the comparably high seroprevalence of these
bloodborne and sexually transmitted infections in Ghana-
ian prison inmates and officers. A concerning finding was
that the prevalence of HCV infection in the prison officers
was even higher than that in prisoners in this study and
previously reported in prisoners in Ghana [19]. Therefore,
the present study substantiates the concern that
PONEIHD may be at significantly increased risk of blood-
borne infections, especially HCV, because of the particu-
larly high prevalence of HCV among prisoners worldwide
[1-8,19,23-31]. The observation of the comparably higher
prevalence of antibodies to these infections among the
prison officers and prisoners, compared to the general
Ghanaian population, is strong presumptive evidence of
intra-prison transmission between prisoners and prison
officers. The cross-sectional scope of the current study did
not allow us to determine whether the prison inmates and
officers acquired the diseases while within or outside of
the prison. However, growing evidence also suggests that
in general, prisoners are more sexually active in the com-
munity than the general population, reporting a higher
number of partners and lower use of condoms [28,30].
Most prisoners have the high-risk behaviours for the
transmission of these infections. Besides illicit drug use,
unsafe sex and homosexuality, prisoners frequently tattoo
their skins out of boredom, and in the process share nee-
dles and ink. These high-risk behaviours place prisoners at
increased risk of infection with blood-borne viruses in
comparison to the rest of the population [22,28,30].
The cross-sectional study design, reliance on self-report-
ing, sociocultural and religious beliefs, and job security/
victimization concerns of the study participants (despite
all our assurances of confidentiality during the explana-
tion of the purpose of the study) may be possible biases
and limitations of the study. In spite of these possible
biases or limitations, this study provides important infor-
mation previously unavailable on prisoners and
PONEIHD in Ghana and can serve as a platform on which
other studies can build. This study would contribute to
efforts to respond to the important healthcare needs of
these vulnerable individuals in Ghana. The results of the
study reveal worrying trends for officials of the Ghana
Prisons Service and the Ministries of Interior and Health,
Accra, Ghana, who are charged with the management of
bloodborne and sexually transmitted infections in the
country. The implications of these findings for HIV, HBV,
HCV and syphilis public health education are obvious.
The results reported herein have significant implications
for penal and public health officials, and suggest the
urgent need for the introduction of policies to prevent the
transmission of these infections in the prison environ-
ment. Even with resource limitations in Africa, effective
partnerships between the prison officials, governmental,
non-governmental and donor organizations would make
headway in addressing issues of prison health as public
health issues in Africa. The development and implemen-
tation of effective prison health initiatives providing
counseling, health education, confidential voluntary test-
ing, care pathways, strategies for interrupting transmis-
sion as well as harm reduction in Ghana is urgent and
long overdue. Such initiatives would ultimately benefit
the inmates, the correctional officers, families, communi-
ties and the general Ghanaian population.BMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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The main focus of these risk reduction efforts should be
on providing access to the prison environment to skilled
infection control practitioners to create a strong safety cli-
mate that is supportive of safe work practices, the use of
safety equipments and other engineering controls, and
urgent implementation and compliance with vaccine rec-
ommendations, especially for HBV. This has to be a
nationwide effort, with support for infection control com-
ing from the highest possible political and administrative
level. A clear, thoughtful, well-planned, and carefully
structured risk reduction approach that targets specific
corrections-related barriers to infection control is urgently
needed for prison officers in Ghana. Additionally, postex-
posure management protocols should be in place, and
prison officers should be well informed about the proce-
dures they should follow in the event of percutaneous
injuries whilst on the job. This training should be docu-
mented, and employee vaccination records should be well
maintained. We also recommend that all prison officers
must be screened at the time of employment to determine
their status with regards to these bloodborne and sexually
transmitted infections, and HBV vaccination offered to
seronegative new hires. Although, the prison inmates and
officers participating in our study cannot be considered
representative of all the prison inmates and officers in
Ghana, the results reported herein have significant impli-
cations for penal and public health officials, suggesting
the importance of introducing policies to prevent trans-
mission of these infections within the prison system.
These policies must include testing programmes in pris-
ons, which should be seen as an opportunity to improve
the health status of the infected prison inmates and offic-
ers, and prevent further transmission of the infectious
agents, within and without the prisons. Finally, we recom-
mend that the prison population (both prison officers
and prisoners) should be included in the routine national
disease surveillance programs of the Ministry of Health so
as to provide a more representative picture of the epidemi-
ology of bloodborne and sexually transmitted infections
in Ghana.
The policy of the Ghana Prison Service is to send prisoners
to any prison in Ghana where there is a vacancy at the
time of committal, and not necessarily to the prison near-
est to the site of crime or the site of trial. Additionally, the
policy of the Ghana Prison Service is to post prison offic-
ers based on rank, expertise and qualification to any
prison in Ghana where there is a vacancy. Hence, the
absence of these two regional central prisons is not likely
to impact the representativeness of our sample. However,
the sociocultural and religious beliefs, and security con-
cerns of the study participants may be additional limita-
tions of the study, despite all our assurances of
confidentiality during the explanation of the purpose of
the study. As a result, some inmates may not have
responded correctly to the parts of the questionnaire relat-
ing to sexual orientation, drug use and history of STD. In
spite of these limitations, the study results provide impor-
tant data on the correlates of HIV, HBV and syphilis infec-
tions among people sent to jail, and may contribute to
efforts to respond to the important healthcare needs of
these vulnerable individuals in Ghana. These policy strat-
egies must include increasing prisoner and correctional
staff education about the prevention of these infections,
testing for and treatment of infected inmates, education in
tattoo application and the provision of professional tat-
tooing services, the provision of bleach, and the provision
of clean injecting equipment [54]. The implementation of
these harm reduction programme in prisoners in Ghana
should be seen as an opportunity to improve the health
status of the infected prison inmates and to prevent fur-
ther transmission of these infections, within and without
the prisons. As a rule, there are inadequate medical facili-
ties and staff in the prisons in Ghana, and access to appro-
priate care outside the Ghana prison system is very
difficult for the inmates. Although the World Health
Organization's (WHO) guidelines for HIV/AIDS in pris-
ons stipulate that all inmates have a right to equitable
health care and that national AIDS programmes should be
applied in jails, this is rarely the case in many African
countries, including Ghana. Ultimately, this approach
benefits not only prisoners but also prison staff and the
public, and does not entail lessening of the safety and
security of prisons. Most inmates eventually get released
and those infected represent a serious risk to their families
and communities as they are reservoirs for further spread
in the general population. Further studies are underway to
determine the modes of transmission, and to institute
interventional measures.
Conclusion
Intravenous drug use, high-risk sexual behaviours, and
low socioeconomic status have resulted in the concentra-
tion of a population infected with HIV, HBV and syphilis
in Ghanaian prisons. Duration of employment in the
prison service, lower socioeconomic status of women, and
high-risk sexual behaviour have resulted in a higher prev-
alence of HIV, HBV, HCV and syphilis in Ghanaian prison
officers, than the general Ghanaian population. The high
prevalence of these bloodborne and sexually transmitted
infections found in Ghanaian prison inmates and officers
suggests the urgent need for the introduction of some of
the range of effective preventive strategies employed in
prisons elsewhere. Despite current financial and institu-
tional constraints, collaborations have to be developed
between the Ghana Prisons Service, local government
authorities, academic and research institutions, non-gov-
ernmental agencies, community-based organizations, and
donor agencies (both local and international) to provideBMC Infectious Diseases 2008, 8:33 http://www.biomedcentral.com/1471-2334/8/33
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effective prison health initiatives and harm reduction
services within the prisons.
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